STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapyin vitroandin vivo
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapyin vitroandin vivo
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 134, Issue 4, Pages 997-1007
Publisher
Wiley
Online
2013-08-12
DOI
10.1002/ijc.28429
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic Amplification of the NOTCH Modulator LNX2 Upregulates the WNT/ -Catenin Pathway in Colorectal Cancer
- (2013) J. Camps et al. CANCER RESEARCH
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
- (2012) M. A. Swartz et al. CANCER RESEARCH
- Rectal cancer
- (2012) Claus Rödel et al. CURRENT OPINION IN ONCOLOGY
- Interleukin-6 - A Key Regulator of Colorectal Cancer Development
- (2012) Maximilian J. Waldner et al. International Journal of Biological Sciences
- Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
- (2012) Pasquale Sansone et al. JOURNAL OF CLINICAL ONCOLOGY
- The molecular basis of chemoradiosensitivity in rectal cancer:implications for personalized therapies
- (2012) Marian Grade et al. LANGENBECKS ARCHIVES OF SURGERY
- STAT3 controls matrix metalloproteinase-1 expression in colon carcinoma cells by both direct and AP-1-mediated interaction with the MMP-1 promoter
- (2011) Constance Zugowski et al. BIOLOGICAL CHEMISTRY
- Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030
- (2011) L Lin et al. BRITISH JOURNAL OF CANCER
- STAT3 Is Necessary for Proliferation and Survival in Colon Cancer-Initiating Cells
- (2011) L. Lin et al. CANCER RESEARCH
- STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma
- (2011) A. Scuto et al. CANCER RESEARCH
- Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy
- (2011) Emil Kendziorra et al. CARCINOGENESIS
- STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers
- (2011) Teppei Morikawa et al. CLINICAL CANCER RESEARCH
- Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors
- (2011) Arun K Mankan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis
- (2011) Yi-Ping Yang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells
- (2010) A. Herrmann et al. CANCER RESEARCH
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets
- (2010) Marian Grade et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic significance of response to preoperative radiotherapy, lymph node metastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer
- (2010) Soichiro Ishihara et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- A Gene Expression Signature for Chemoradiosensitivity of Colorectal Cancer Cells
- (2010) Melanie Spitzner et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Inhibition of STAT3 and ErbB2 Suppresses Tumor Growth, Enhances Radiosensitivity, and Induces Mitochondria-Dependent Apoptosis in Glioma Cells
- (2010) Ling Gao et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trial
- (2010) F. Monnien et al. JOURNAL OF CLINICAL PATHOLOGY
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- Cucurbitacin I Suppressed Stem-Like Property and Enhanced Radiation-Induced Apoptosis in Head and Neck Squamous Carcinoma-Derived CD44+ALDH1+ Cells
- (2010) Y.-W. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome
- (2009) George J. Chang et al. CANCER
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease
- (2009) Stefan Rose-John et al. CURRENT PHARMACEUTICAL DESIGN
- Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer
- (2009) Jordi Camps et al. GENES CHROMOSOMES & CANCER
- Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma
- (2009) James A. Bonner et al. RADIOTHERAPY AND ONCOLOGY
- Signaling Molecules: The Pathogenic Role of the IL-6/STAT-3 Trans Signaling Pathway in Intestinal Inflammation and in Colonic Cancer
- (2008) R. Atreya et al. CURRENT DRUG TARGETS
- The role of signal transducers and activators of transcription in colon cancer
- (2007) Lidija Klampfer Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now